No surprise .... ongoing missed targets, expectati
Post# of 36537
(Total Views: 325)
Posted On: 06/30/2021 10:51:53 AM
No surprise .... ongoing missed targets, expectations, poor finances, no management credibility ...responsible for nonstop dilution and unable to fund, still no listing , failed "vision" results so far, Shareholder "unlocked" value still locked up, Merck/AE37 trial on hold, Gofundme appears dead and stuck at $1005 after 3 months.
The blah blah blah continues, Joe counting on science to bail out his two year poor performance. Any CEO would have been fired or replaced but not at this company......... no wonder big money hesitant to support if this close to "complete vaccine" ........ don't think the world is waiting for GNBT/NGIO ........ a boost is not a big deal if necessary.
We can read all the articles regarding issues with current vaccines but they work , Big Pharma continues to improve and show credibility.
Accuracy not a goal, PR's are just announcements to buy time and hopefully increase pps to dump more shares.
If highly confident and solid progress they should have solid funding lined up ........
no funding and or credibility = PPS
The blah blah blah continues, Joe counting on science to bail out his two year poor performance. Any CEO would have been fired or replaced but not at this company......... no wonder big money hesitant to support if this close to "complete vaccine" ........ don't think the world is waiting for GNBT/NGIO ........ a boost is not a big deal if necessary.
We can read all the articles regarding issues with current vaccines but they work , Big Pharma continues to improve and show credibility.
Accuracy not a goal, PR's are just announcements to buy time and hopefully increase pps to dump more shares.
If highly confident and solid progress they should have solid funding lined up ........
no funding and or credibility = PPS
(2)
(1)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼